Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial

Nancy Y. Lee, Robert L. Ferris, Amanda Psyrri, Robert I. Haddad, Makoto Tahara, Jean Bourhis, Kevin J. Harrington, Peter Mu‐Hsin Chang, Jin‐Ching Lin, Mohammad Razaq, Maria Margarida Teixeira, József Lövey, J. Chamois, Antonio Rueda, Chaosu Hu, Lara Dunn, Mikhail Dvorkin, Steven De Beukelaer, Dmitri Pavlov, Holger Thurm, Ezra E.W. Cohen